Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Similar articles for PubMed (Select 8102666)

1.

Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus.

Aoki TT, Benbarka MM, Okimura MC, Arcangeli MA, Walter RM Jr, Wilson LD, Truong MP, Barber AR, Kumagai LF.

Lancet. 1993 Aug 28;342(8870):515-8.

PMID:
8102666
2.
3.

Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG.

Diabetes Care. 1997 Jan;20(1):59-63.

PMID:
9028695
5.

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

Schnell O, Eisfelder B, Standl E, Ziegler AG.

Diabetes. 1997 Oct;46(10):1607-11.

PMID:
9313757
6.

Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.

Tsui EY, Chiasson JL, Tildesley H, Barnie A, Simkins S, Strack T, Zinman B.

Diabetes Care. 1998 Jan;21(1):93-6.

PMID:
9538976
7.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
8.

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

Diabetes Care. 2002 Nov;25(11):2074-80.

PMID:
12401759
9.
10.

Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.

Hanas R, Adolfsson P.

Pediatr Diabetes. 2006 Feb;7(1):25-31. Erratum in: Pediatr Diabetes. 2006 Oct;7(5):298.

PMID:
16489971
13.

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.

PMID:
18502299
14.

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA.

Diabetes Technol Ther. 2008 Oct;10(5):377-83. doi: 10.1089/dia.2008.0068.

PMID:
18715214
15.
16.
17.

Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

Diabetes Care. 1998 Oct;21(10):1627-31.

PMID:
9773721
18.

[Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin].

Jaffiol C, Jacques-Apostol D, Renard E, Millet P, Compeyre S, Lauton D, Picot MC, Bringer J.

Bull Acad Natl Med. 1996 Jan;180(1):177-91; discussion 191-4. French.

PMID:
8696875
19.
20.

Long-term safety and efficacy of programmable implantable insulin delivery systems.

Olsen CL, Liu G, Iravani M, Nguyen S, Khourdadjian K, Turner DS, Waxman K, Selam JL, Charles MA.

Int J Artif Organs. 1993 Dec;16(12):847-54.

PMID:
8175202
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk